Clinical Trial

Efficacy and Safety With Early Treatment of Finerenone in Hospitalized Patients With Heart Failure

Study acronym: FACILITATE-HF
Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
FACILITATE-HF is a multicenter, randomized, double-blind, placebo-controlled trial designed to determine whether initiation of finerenone during the early phase of hospitalization has beneficial effects in patients with AHF who have left ventricular ejection fraction 40% or more.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-02-02.
Trial Details
NCT Number NCT07397650
Lead Sponsor Juntendo University
Conditions Acute Heart Failure
Enrollment 550 participants
Start Date 2026-05-11
Primary Completion 2027-12 (estimated)
Study Completion 2028-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-10